Shortly after raising $10 million CAD in Series A funding, Kitchener-based healthtech startup Nicoya has launched what it calls “the world’s first digital benchtop SPR system,” which aims to help make drug discovery faster. Established in 2012, Nicoya develops nanotechnology, biochemistry, and optical sensor technologies used by medical researchers in both academic and private institutions in more than 25 countries. The startup graduated from the Kitchener-Waterloo-based Accelerator Centre in 2015. To date, Nicoya has received overall financing of more than $14.6 million CAD from ventures and government funding.